Open AccessClinical outcomes with first-line chemotherapy versus endocrine therapy for adjuvant endocrine therapy-resistant metastatic breast cancer
Author(s) -
Bin Shao,
Jinrong Qu,
Huiping Li,
Guohong Song,
Lijun Di,
Hanfang Jiang,
Ying Yan,
Huan Wang,
Xiaoran Liu,
Jing Wang,
Weiyao Kong
Publication year - 2018
Publication title -
translational cancer research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.254
H-Index - 30
eISSN - 2219-6803
pISSN - 2218-676X
DOI - 10.21037/tcr.2018.05.43
Subject(s) - medicine , metastatic breast cancer , oncology , breast cancer , chemotherapy , cancer , adjuvant , adjuvant therapy , endocrine system , metastasis , estrogen receptor , progression free survival , stage (stratigraphy) , hormone , paleontology , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom